Market Overview:
The global thoracic outlet syndrome treatment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing incidence of thoracic outlet syndrome, rising awareness about the condition, and technological advancements in the field of thoracic outlet syndrome treatment. The global thoracic outlet syndrome treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into surgery, medication, physical therapy, and others. On the basis of application, it is divided into hospitals & clinics; diagnostic centers; research institutes & universities; and others (including military establishments).
Product Definition:
Thoracic outlet syndrome (TOS) is a condition that results when the nerves and/or blood vessels in the thoracic outlet are compressed. The thoracic outlet is a passageway between the neck and chest that contains the nerves and blood vessels that supply the arm. TOS can cause pain, numbness, tingling, weakness, or other symptoms in the arm.
Surgery:
The global surgery, it's usage and growth factor in TOS treatment market size was valued at USD 1.0 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. Increasing prevalence of thoracic outlet syndrome (TOS) globally is one of the key factors driving demand for surgeries, thereby providing potential growth platform to this market throughout the forecast horizon.
Medication:
Medication and its usage in thoracic outlet syndrome treatment market is a branch of medicine that deals with disorders occurring in the chest. Medications are used for treating pain, pressure, and other symptoms associated with thoracic outlet syndrome. The most common symptom includes cough that does not go away even after taking deep breath. Other symptoms include fatigue, shortness of breath, wheezing or asthma like symptoms etc.
Application Insights:
The others application segment held the largest share of over 50.0% in 2017. This is due to the increasing prevalence of conditions such as rheumatoid arthritis, osteoarthritis, and fibromyalgia which are associated with TOS. Thus, a large patient base requiring treatment is expected to drive the demand for thoracic outlet syndrome treatment across clinics and other healthcare facilities globally during the forecast period.
Hospitals were estimated to be the largest revenue-generating centers for THORACIC OUTLET SYNDROME TREATMENT owing to factors such as availability of advanced healthcare facilities along with highly skilled medical personnel 24*7*365 who can cater to emergency as well as urgent care requirements resulting in high market penetration in this segment over recent years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the high prevalence of thrombosis and related disorders, favorable reimbursement policies, and increasing awareness about TOS treatment options. In addition, rising healthcare expenditure by government entities as well as private players is expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and growing patient awareness levels regarding available treatment options for TOS symptoms. Moreover, an increase in medical tourism due to affordable treatments offered by local clinics will boost demand for various procedures associated with this condition in this region during the estimated time span.
Growth Factors:
- Increasing incidence of thoracic outlet syndrome (TOS) due to changing lifestyle and increasing awareness about the disease.
- Growing demand for minimally invasive surgeries for TOS treatment.
- Technological advancements in surgical procedures for TOS treatment.
- Rising number of research and development activities focused on TOS treatment market growth drivers 5 Increased focus on early diagnosis and prevention of thoracic outlet syndrome will fuel the growth of this market in the coming years
Scope Of The Report
Report Attributes
Report Details
Report Title
Thoracic Outlet Syndrome Treatment Market Research Report
By Type
Surgery, Medication, Physical Therapy, Others
By Application
Hospitals, Clinics, Diagnostic Centers, Others
By Companies
Sanofi, Abbott, Bayer, Johnson & Johnson, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Endo Pharmaceuticals, SteriMax, Upsher Smith Laboratories, Mallinckrodt, Orient Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
189
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Thoracic Outlet Syndrome Treatment Market Report Segments:
The global Thoracic Outlet Syndrome Treatment market is segmented on the basis of:
Types
Surgery, Medication, Physical Therapy, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Diagnostic Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Abbott
- Bayer
- Johnson & Johnson
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Daiichi Sankyo
- Endo Pharmaceuticals
- SteriMax
- Upsher Smith Laboratories
- Mallinckrodt
- Orient Pharma
Highlights of The Thoracic Outlet Syndrome Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Surgery
- Medication
- Physical Therapy
- Others
- By Application:
- Hospitals
- Clinics
- Diagnostic Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thoracic Outlet Syndrome Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no specific treatment for thoracic outlet syndrome, but various treatments may be tried depending on the severity of the condition. Treatment may include physical therapy, breathing exercises, and medications.
Some of the key players operating in the thoracic outlet syndrome treatment market are Sanofi, Abbott, Bayer, Johnson & Johnson, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Endo Pharmaceuticals, SteriMax, Upsher Smith Laboratories, Mallinckrodt, Orient Pharma.
The thoracic outlet syndrome treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Thoracic Outlet Syndrome Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Thoracic Outlet Syndrome Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Thoracic Outlet Syndrome Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Thoracic Outlet Syndrome Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Thoracic Outlet Syndrome Treatment Market Size & Forecast, 2018-2028
4.5.1 Thoracic Outlet Syndrome Treatment Market Size and Y-o-Y Growth
4.5.2 Thoracic Outlet Syndrome Treatment Market Absolute $ Opportunity
Chapter 5 Global Thoracic Outlet Syndrome Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Thoracic Outlet Syndrome Treatment Market Size Forecast by Type
5.2.1 Surgery
5.2.2 Medication
5.2.3 Physical Therapy
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Thoracic Outlet Syndrome Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Thoracic Outlet Syndrome Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Diagnostic Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Thoracic Outlet Syndrome Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Thoracic Outlet Syndrome Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Thoracic Outlet Syndrome Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Thoracic Outlet Syndrome Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Thoracic Outlet Syndrome Treatment Market Size Forecast by Type
9.6.1 Surgery
9.6.2 Medication
9.6.3 Physical Therapy
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Thoracic Outlet Syndrome Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Diagnostic Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Thoracic Outlet Syndrome Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Thoracic Outlet Syndrome Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Thoracic Outlet Syndrome Treatment Market Size Forecast by Type
10.6.1 Surgery
10.6.2 Medication
10.6.3 Physical Therapy
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Thoracic Outlet Syndrome Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Diagnostic Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Thoracic Outlet Syndrome Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Thoracic Outlet Syndrome Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Thoracic Outlet Syndrome Treatment Market Size Forecast by Type
11.6.1 Surgery
11.6.2 Medication
11.6.3 Physical Therapy
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Thoracic Outlet Syndrome Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Diagnostic Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Thoracic Outlet Syndrome Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Thoracic Outlet Syndrome Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Thoracic Outlet Syndrome Treatment Market Size Forecast by Type
12.6.1 Surgery
12.6.2 Medication
12.6.3 Physical Therapy
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Thoracic Outlet Syndrome Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Diagnostic Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Thoracic Outlet Syndrome Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Thoracic Outlet Syndrome Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Thoracic Outlet Syndrome Treatment Market Size Forecast by Type
13.6.1 Surgery
13.6.2 Medication
13.6.3 Physical Therapy
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Thoracic Outlet Syndrome Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Diagnostic Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Thoracic Outlet Syndrome Treatment Market: Competitive Dashboard
14.2 Global Thoracic Outlet Syndrome Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Abbott
14.3.3 Bayer
14.3.4 Johnson & Johnson
14.3.5 Boehringer Ingelheim
14.3.6 Bristol-Myers Squibb
14.3.7 Daiichi Sankyo
14.3.8 Endo Pharmaceuticals
14.3.9 SteriMax
14.3.10 Upsher Smith Laboratories
14.3.11 Mallinckrodt
14.3.12 Orient Pharma
